Delcath Systems (DCTH -12.9%) opens sharply lower after the FDA posts a briefing document for...

|About: Delcath Systems, Inc. (DCTH)|By:, SA News Editor

Delcath Systems (DCTH -12.9%) opens sharply lower after the FDA posts a briefing document for the Oncologic Drugs Advisory Committee's discussion of DCTH's ocular melanoma injection Melblez on its website.